Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Patients With Tiletamine Use Disorder: A Randomized Double-Blind Sham-Controlled Trial

NCT07689981 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT07689981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07689981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Patients With Tiletamine Use Disorder: A Randomized Double-Blind Sham-Controlled Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
January 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug craving, substance use disorder (sud), tiletamine use disorder